PDCD1 and melanoma: identified distinct subsets of CD8+ Tex cells with varying roles in tumor control and ICI responses, reporting that only “progenitor exhausted” TILs, which retain polyfunctionality and persist long‐term, respond to anti‐PD‐1 therapy and correlate with prolonged responses in melanoma.[103] Likewise, Liu et al.